Application deadline: August 28, 2025

Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they…

Deadline: September 26, 2025

European test infrastructure for AI in healthcare

Meeting Point: Byron Bar, in front of the Bayer Campus in Berlin

The Charité Center for Global Health and the WHO Hub for Pandemic and Epidemic Intelligence, both based in Berlin, Germany, have launched a visiting fellowship to strengthen research in public health intelligence.

Deadline: Monday July 7th, 2025

Frailty is a condition characterized by increased vulnerability and decline in physical function. It is a growing concern in the aging population, particularly among those with heart disease. A multidisciplinary research team led by the German…

The MRI image shows a brain tumor in an inauspicious location, – and a brain biopsy will entail high risks for the patient, who had consulted us due to double vision. Situations such as this case discussion, cited by way of example, in a…

Eckert & Ziegler (ISIN DE0005659700, TecDAX) congratulates Telix Pharmaceuticals Limited (Telix) on the approval of its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection) in Germany, where Eckert…